SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-029795
Filing Date
2020-06-18
Accepted
2020-06-18 16:12:40
Documents
14
Period of Report
2020-06-12
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-8k_20200612.htm   iXBRL 8-K 41208
2 EX-99.1 asmb-ex991_15.htm EX-99.1 14451
3 GRAPHIC gpnmu3bg1m0m000001.jpg GRAPHIC 2994
  Complete submission text file 0001564590-20-029795.txt   191695

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA asmb-20200612.xsd EX-101.SCH 5788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20200612_lab.xml EX-101.LAB 18731
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20200612_pre.xml EX-101.PRE 11182
10 EXTRACTED XBRL INSTANCE DOCUMENT asmb-8k_20200612_htm.xml XML 3444
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 20972676
SIC: 2834 Pharmaceutical Preparations